Gemina Laboratories Ltd. (GLAB.CN)

CAD 0.58

(-8.0%)

Total Debt Summary of Gemina Laboratories Ltd.

  • Gemina Laboratories Ltd.'s latest annual total debt in 2023 was 285.32 Thousand CAD , up 18.47% from previous year.
  • Gemina Laboratories Ltd.'s latest quarterly total debt in 2024 Q1 was 1.26 Million CAD , up 343.82% from previous quarter.
  • Gemina Laboratories Ltd. reported annual total debt of 240.84 Thousand CAD in 2022, up 422.68% from previous year.
  • Gemina Laboratories Ltd. reported annual total debt of 46.07 Thousand CAD in 2021, down -53.04% from previous year.
  • Gemina Laboratories Ltd. reported quarterly total debt of 1.18 Million CAD for 2024 Q2, down -6.21% from previous quarter.
  • Gemina Laboratories Ltd. reported quarterly total debt of 321.3 Thousand CAD for 2023 Q2, up 39.31% from previous quarter.

Annual Total Debt Chart of Gemina Laboratories Ltd. (2023 - 2020)

Historical Annual Total Debt of Gemina Laboratories Ltd. (2023 - 2020)

Year Total Debt Total Debt Growth
2023 285.32 Thousand CAD 18.47%
2022 240.84 Thousand CAD 422.68%
2021 46.07 Thousand CAD -53.04%
2020 98.12 Thousand CAD 0.0%

Peer Total Debt Comparison of Gemina Laboratories Ltd.

Name Total Debt Total Debt Difference
Algernon Pharmaceuticals Inc. - CAD -Infinity%
Asep Medical Holdings Inc 20 Thousand CAD -1326.63%
BetterLife Pharma Inc. 245.23 Thousand CAD -16.348%
BioVaxys Technology Corp. - CAD -Infinity%
ChitogenX Inc. 3.87 Million CAD 92.637%
Rapid Dose Therapeutics Corp. 2.45 Million CAD 88.371%
Defence Therapeutics Inc. 1.74 Million CAD 83.662%
Entheon Biomedical Corp. - CAD -Infinity%
Glow Lifetech Corp. 116.18 Thousand CAD -145.581%
Lexston Life Sciences Corp. - CAD -Infinity%
Pharmala Biotech Holdings Inc. 253.53 Thousand CAD -12.538%
Doseology Sciences Inc. - CAD -Infinity%
MYND Life Sciences Inc. 3 Million CAD 90.489%
Nova Mentis Life Science Corp. - CAD -Infinity%
PharmaTher Holdings Ltd. - CAD -Infinity%
PreveCeutical Medical Inc. 3.83 Million CAD 92.558%
Telescope Innovations Corp. - CAD -Infinity%